From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management? - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue JHEP Reports Innovation in Hepatology Année : 2021

From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?

Résumé

Heart failure and liver disease often coexist because of systemic disorders and diseases that affect both organs as well as complex cardio-hepatic interactions. Heart failure can cause acute or chronic liver injury due to ischaemia and passive venous congestion, respectively. Congestive hepatopathy is frequently observed in patients with congenital heart disease and after the Fontan procedure, but also in older patients with chronic heart failure. As congestive hepatopathy can evolve into cirrhosis and hepatocellular carcinoma, screening for liver injury should be performed in patients with chronic cardiac diseases and after Fontan surgery. Fibrosis starts in the centro-lobular zone and will extend progressively to the portal area. Chronic liver injury can be reversible if heart function improves. However, in the case of terminal heart failure, uncontrolled by medical resources or by assistive device support, the combination of heart and liver transplants must be discussed in patients with chronic advanced liver fibrosis. In this review of the literature, we will focus on congestive hepatopathy and its complications, such as liver fibrosis and hepatocellular carcinoma, with the aim of improving the management and surveillance of patients experiencing these complications.
Fichier principal
Vignette du fichier
PIIS2589555921000252.pdf (1.06 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-03185225 , version 1 (30-03-2021)

Identifiants

Citer

Anna Sessa, Manon Allaire, Pascal Lebray, Mourad Medmoun, Alberto Tiritilli, et al.. From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?. JHEP Reports Innovation in Hepatology, 2021, 3 (2), pp.100249. ⟨10.1016/j.jhepr.2021.100249⟩. ⟨hal-03185225⟩
18 Consultations
52 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More